Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
boston blog main
boulder/denver blog main
detroit blog main
indiana blog main
national
national blog main
national top stories
new york blog main
raleigh-durham blog main
san diego blog main
san francisco blog main
seattle blog main
4
×
texas blog main
texas top stories
wisconsin blog main
boston top stories
boulder/denver top stories
detroit top stories
fda
indiana top stories
life sciences
new york top stories
raleigh-durham top stories
san diego top stories
san francisco top stories
seattle top stories
wisconsin top stories
alex azar
biotech
department of health and human services
drug prices
medicare
president trump
regeneron pharmaceuticals
scott gottlieb
alirocumab
alliance for aging research
american patients first
amgen
biogen
What
trump
4
×
administration
awaited
drug
drugs
house
long
plan
unveiled
white
afternoon
angry
anti
anticipated
benefited
blueprint
business
canada
canadian
cheaper
comes
company
control
cost
costly
countries
cut
department
despite
details
developing
effect
excludes
execs
external
factors
fear
floats
founders
health
Language
unknown
Current search:
trump
×
photo
×
" seattle blog main "
×
@xconomy.com
4 years ago
White House Floats Canadian Import Plan But Excludes Many Costly Drugs
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans
@xconomy.com
5 years ago
From Immigration to Taxes, Execs Talk Trump Effect on Innovation
@xconomy.com
5 years ago
Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details